Mikrogen Diagnostik recomWell SARS-CoV-2 IgA ELISA Kit

$731.00

Host Quantity Applications Species Reactivity Data Sheet  
96 Tests ELISA SARS-CoV-2
SKU: 7305 Categories: ,
Overview
Product Name Mikrogen Diagnostik recomWell SARS-CoV-2 IgA ELISA Kit (7305)
Description Enzyme immunoassay with antigens produced by recombinant techniques for the detection of IgG and IgA antibodies against the coronavirus SARS-CoV-2 in human serum or plasma.

Product is intended for research use.
Target Human SARS-CoV-2 IgA
Product Background In December 2019 began in the city of Wuhan, capital of Hubei in China, a pandemic spread of the disease caused by a new variant of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). The newly discovered variant is called SARS-CoV-2 and is closely related to SARS-CoV(-1). SARS coronaviruses spread primarily via droplets in exhaled air to transmit from person to person.Symptoms range from fever, cough and dyspnoea to pneumonia and acute respiratory distress syndrome and ultimately death in persons with comorbidities. Since the end of 2020, several vaccines against SARS-CoV-2 have been approved, most of which target the spike protein of the virus that mediates contact with the host cell.According to the German Robert Koch Institute, infected persons usually develop detectable antibodies in the second week after the onset of symptoms. A seroconversion or a significant increase in titer for IgG antibodies in the same test system can indicate an acute infection, especially in combination with corresponding symptoms. Thus, serological detection of antibodies serves as an ideal addition to molecular detection, which is recommended for acute diagnostics. Furthermore, the detection of IgG antibodies is a clear indication of pathogen contact and can detect a past infection and can be used for epidemiological studies.Product advantages for your benefitVery high sensitivity and specificity due to the use of highly purified recombinant nucleocapsid antigenEasy test procedure in the automatable ELISA screening format; quantitative resultsIdentical processing as well as uniform and interchangeable reagents for all MIKROGEN recomWell ELISABreak-aparts: single sample examination possibleCE label: The recomWell SARS-CoV-2 IgG, IgA tests meet the high standards of the European directive 98/79/EC on in vitro diagnostic medical devices
Species Reactivity SARS-CoV-2
Assay Type Indirect ELISA
Applications ELISA
Properties
Background In December 2019 began in the city of Wuhan, capital of Hubei in China, a pandemic spread of the disease caused by a new variant of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). The newly discovered variant is called SARS-CoV-2 and is closely related to SARS-CoV(-1). SARS coronaviruses spread primarily via droplets in exhaled air to transmit from person to person.Symptoms range from fever, cough and dyspnoea to pneumonia and acute respiratory distress syndrome and ultimately death in persons with comorbidities. Since the end of 2020, several vaccines against SARS-CoV-2 have been approved, most of which target the spike protein of the virus that mediates contact with the host cell.According to the German Robert Koch Institute, infected persons usually develop detectable antibodies in the second week after the onset of symptoms. A seroconversion or a significant increase in titer for IgG antibodies in the same test system can indicate an acute infection, especially in combination with corresponding symptoms. Thus, serological detection of antibodies serves as an ideal addition to molecular detection, which is recommended for acute diagnostics. Furthermore, the detection of IgG antibodies is a clear indication of pathogen contact and can detect a past infection and can be used for epidemiological studies.Product advantages for your benefitVery high sensitivity and specificity due to the use of highly purified recombinant nucleocapsid antigenEasy test procedure in the automatable ELISA screening format; quantitative resultsIdentical processing as well as uniform and interchangeable reagents for all MIKROGEN recomWell ELISABreak-aparts: single sample examination possibleCE label: The recomWell SARS-CoV-2 IgG, IgA tests meet the high standards of the European directive 98/79/EC on in vitro diagnostic medical devices
Sample Type Serum, plasma, whole blood
Assay Resolution See Figure
Components
10X Wash Buffer100 mL
Dilution Buffer125 mL
TMB Substrate12 mL
Stop Slution12 mL
Instuctions for Use1 Each
Evaluation Form1 Each
Microplate Sealing Tape2 Each
Microtiter Plate12 x 8 Wells
Positive Control450 uL
Cut-Off Control450 uL
Negative Control450 uL
Anti-Human IgA Conjugate500 uL
Specificity Information
Target ID Human SARS-CoV-2 IgA
Research Areas Infectious Disease
Application Images
Description Test principle and procedure.
Description Sensitivity
Description Specificity
Additional Information
Handling
Storage Store at 2 - 8°C. Do not Freeze.
References & Data Sheet